Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL741565 | 1.00 | GRM2 (0.62) | GRM2KCNH2 | |
| SCHEMBL10324070 | 0.89 | GRM2 (0.63) | GRM2 | |
| SCHEMBL740689 | 0.86 | GRM2 (0.64) | GRM2KCNH2 | |
| SCHEMBL739599 | 0.82 | GRM2 (0.80) | GRM2KCNH2 | |
| SCHEMBL741672 | 0.79 | GRM2 (0.75) | GRM2 | |
| SCHEMBL30795978 | 0.78 | GRM2 (0.76) | GRM2KCNH2 | |
| SCHEMBL739577 | 0.78 | GRM2 (0.76) | GRM2KCNH2 | |
| SCHEMBL740217 | 0.77 | GRM2 (1.00) | GRM2KCNH2 | |
| SCHEMBL30796090 | 0.77 | GRM2 (1.00) | GRM2KCNH2 | |
| SCHEMBL741976 | 0.76 | GRM2 (0.73) | GRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4584250-A1 | COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS | Biohaven Therapeutics Ltd. (VG) | 2025-07-16 | — | — | EP | disclosed |
| WO-2024054811-A1 | COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS | BIOHAVEN THERAPEUTICS LTD. (VG) | 2024-03-14 | — | — | WO | disclosed |